Trinity Biotech R1129
by Trinity Biotech Public Limited Company
Trinity Biotech R1129 is a medical device (FDA Class II; FDA product code JBL, Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Quantitative) made by Trinity Biotech Public Limited Company, cleared under FDA 510(k) K790211 on 15 Mar 1979 and listed in FDA GUDID since 23 Sep 2016 (UDI-DI 05391516743228), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number05391516743228 | Date23 Sep 2016 | StatusListed |
| United States | FDA 510(k)SESE | NumberK790211 | Date15 Mar 1979 | StatusActive |
Official records
- AccessGUDID record 05391516743228
- FDA 510(k) database K790211
From the FDA record
- Device description
- Red Cell Lysing Reagent (4 x 25mL)
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K790211 decided 15 Mar 1979 Active
- FDA GUDID UDI-DI 05391516743228 listed 23 Sep 2016 Listed
Timeline
- Cleared FDA 510(k) K790211
- Listed FDA GUDID 05391516743228
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Trinity Biotech
- Generic name
- Red cell glucose-6-phosphate dehydrogenase (G6PD) IVD, reagent
- Model / Ref / Catalog
- R1129
- Primary DI / UDI-DI
- 05391516743228
- 510(k) Number
- FDA product code
- JBL
- GMDN term
- Red cell glucose-6-phosphate dehydrogenase (G6PD) IVD, reagent
- Device class
- Class II
- Regulation number
- 864.7360
- GUDID distribution status
- In Commercial Distribution
Other devices from Trinity Biotech Public Limited Company
See all devices from Trinity Biotech Public Limited Company →